Clinical Trial: Resynchronisation Therapy of Right Ventricle in Pulmonary Arterial Hypertension

Study Status: Completed
Recruit Status: Unknown status
Study Type: Interventional

Official Title: Resynchronisation Therapy of Right Ventricle in Pulmonary Arterial Hypertension

Brief Summary:

Pulmonary arterial hypertension is a disease characterised by pathological changes in the pulmonary arteries leading to a progressive increase in pulmonary vascular resistance and pulmonary artery pressure. Right ventricular failure is the main cause of death in patients with pulmonary arterial hypertension, and the ability of the right ventricle to adapt to the progressive increase in pulmonary vascular resistance associated with changes to the pulmonary vasculature in pulmonary arterial hypertension is the main determinant of a patient's functional capacity and survival.

Right ventricular dyssynchrony was present in a substantial proportion of patients with pulmonary arterial hypertension and this dyssynchrony adversely affected right ventricular function.

Detailed Summary:
Sponsor: University Hospital, Caen

Current Primary Outcome: cardiac index measured during right catheterization [ Time Frame: After two minutes of right stimulation ]

Original Primary Outcome: Same as current

Current Secondary Outcome:

Original Secondary Outcome:

Information By: University Hospital, Caen

Dates:
Date Received: July 18, 2013
Date Started: July 2013
Date Completion: June 2014
Last Updated: April 8, 2014
Last Verified: April 2014